July 16, 2020 — Whole body positron emission tomography (PET) has, for the first time, illustrated the existence of ...
PET Imaging
Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.
July 16, 2020 — New research confirms the high impact of PSMA PET/CT in the detection and management of recurrent ...
July 16, 2020 — Results from the first study using uEXPLORER to conduct total-body dynamic positron emission tomography ...
Digital technology is opening remarkable opportunities for clinical positron emission tomography (PET) about which ...
July 15, 2020 — Targeted radionuclide therapy has been found to create a favorable tumor microenvironment in prostate ...
July 15, 2020 — A first-in-human study presented at the Society of Nuclear Medicine and Molecular Imaging 2020 Annual ...
June 1, 2020 — TAUVID, a radioactive diagnostic agent, has been approved by the FDA for positron emission tomography ...
Precision can have an enormous impact on patients. From diagnosis to patient monitoring (see “How Digital PET/CT Can ...
June 1, 2020 — RefleXion Medical, a therapeutic oncology company pioneering biology-guided radiotherapy (BgRT) for ...
May 27, 2020 — PETNET Solutions, Inc., a Siemens Healthineers company, and Zionexa USA, a wholly owned subsidiary of ...
May 14, 2020 — New imaging technology allows scientists to see the widespread loss of brain synapses in early stages of ...
PET is getting ready to venture outside oncology, cardiology and mainstream neurology. High on the list of new clinical ...
April 10, 2020 — Combining 89Zr-labeled antibodies with total-body positron emission tomography (PET) has extended the ...
April 9, 2020 — RefleXion Medical, a therapeutic oncology company pioneering the use of biology-guided radiotherapy ...
Hicham Skali, M.D., a staff cardiologist and member of the Non-invasive Cardiovascular Imaging Program at Brigham and ...
Analog is approximate. Digital is specific. Therein lies the fundamental difference between digital PET and its analog ...
April 3, 2020 — A new guidance document on best practices to maintain safety and minimize contamination in nuclear ...
February 28, 2020 — MR Solutions will be displaying its latest dry magnet 3T to 9.4T preclinical, multi-modality MRI ...
January 27, 2020 — Researchers have identified several potentially useful breast cancer biomarkers that indicate the ...
January 27, 2020 — According to the new market research report "Nuclear Medicine Market by Type (Diagnostic (SPECT - ...
December 26, 2019 — The Feinstein Institutes for Medical Research has received U.S. Food and Drug Administration (FDA) ...
November 25, 2019 – At this year’s Radiological Society of North America (RSNA) annual meeting, Canon Medical Systems ...
November 15, 2019 — Theragnostics, which is developing innovative radiopharmaceuticals to improve cancer diagnosis and ...
October 16, 2019 — GE Healthcare and Theragnostics have entered into a global commercial partnership for a new prostate ...
July 16, 2020 